According to the research conducted by the scientists at McLean Hospital and Nanyang Technical University, Singapore, these two molecules, though available in short supply in the brains of the patients, can stimulate the production of dopamine that may act effectively in reversing the advancement of the Parkinson’s disease.Original Article
You may also like
A Temporary Extension for the Rare Pediatric Disease...
Survey Says 25% Of Adults In U.S Suspect They Have...
Your Child’s Bedtime Affects Their Gut Health:...
Quality, Not Quantity Of Good Cholesterol Linked To...
Atueyi Tasks Pharmacy Students on Critical Thinking
Best Oil Cleansers: Top Solutions For Deep Cleansing...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.